Member Info for SLF72

I've been wondering this for a while now and the time has come, hoping there are some informed types out there willing to answer.

How from a blood test do you determine there is a breast cancer? Are the captured cells themselves identifying the site, in this case breast?

Presumably not, because then the same test would identify the site of any cancer.. What haven't I understood?

Maybe we should just be thankful no one expects us to turn the places we work into £b companies before we're allowed to move house.

Likewise, high conviction.

Fda approval is the only thing holding this back. On A+1, we're a company with something to sell.
It won't take much news after approval and 80p will be left well behind.

there's plenty of institutions that will hold stock below an issue price, i imagine deliveroo and certainly TILS are reasonable examples of companies that have raised and tanked.
do institutions never shut shop?

no one is going to like major dilution but i guess the reality is digging big holes and analysing whether there's anything worthwhile down there, then having to bring it up and move it is an expensive business, that has to be paid for.
this should be fine as long as they can follow through like Phil has already suggested.

the half year interims here suggest about breakeven for the previous 6 months. that included the 2nd qtr being significantly ahead of the 1st quarter. both clearly without any new AVCT volume.

Avct now say their main concern is supply! that suggests they expect to be able to take everything that ABDX could produce.

So how much profit could ABDX make running at full expanded capacity? i dont know, but it feels like it should be good enough to justify an SP improvement.

i did. it was a beautiful thing.

this dispassionate 'no knowledge' TA method makes a lot of sense. i've been looking at charts a little over the last few weeks, but seeing as i don't think i've based any decisions on it, it must just be because i like the pretty colours.

my 'company analysis' tells me i love AGL and i've just got to sit tight to increase my capital. but i can totally see that does not mean a TA approach is in any way necessarily less valid or profitable. in fact, thinking about it now, i guess it fundamentally does safe guard my investment. (having lost everything at THQ a few yrs back, and having suffered horribly more recently on AGM, BYOT, BARC, BPC.)

Wyn, you've mentioned 'support' are you just identifying this by looking at the levels at which an rsi has reversed in the past?

thanks for confirming this was an LSE board.

after reading with interest a sensible discussion with DIFFERING views and approaches and not seeing any sign of abuse, I thought I must have got lost.

maybe its you lot that are lost!! :)

How many Americans have passports nowadays?

£12 isn't too late. that's when AN starts answering calls.

we've blown past £1, and we've hardly got our shoes on!

All our shares are going to be free at this rate.

Chuckle

Credit where credit is due. I've got the Idiott to thank for bringing my attention to this a while ago.
Aswell as potentially massive financial upside, it is great to be keeping up with something so fundamentally interesting and worthwhile.

Yep, it would basically be a massive dilution.

Good to get the coverage. I'm not sure 'blood test' really does it justice though.

The initial value for accustom will be a fraction of 800m$.
20% of that would be bullish.

Frankly, I've got no idea of nasdaq requirements but I wonder if the 4usd is achieved in the same manner that Tils is listed. I don't think it's a consolidation it's just a bundle of shares. You have to buy 1 unit worth 5 shares, giving a price of 4usd.

Ive always been really excited about accustom but even I'm starting to wonder about its future when they struggle to sort out its present.

Anyway. Am I too late for my free shares?

wow! and still reading the board! you deserve to do well.

Surely this has got to start moving when production and revenue really bed's in. Long before full production is reached the business plan must be almost entirely derisked. For lake 1 anyway.
Maybe for a bagger they need to prove lake 2 can be brought online without any unfortunate funding f'ups.

Yep, as yuyus says. It's a brilliant link.

Time to average up.

You're right and that makes a nonsense of the maths. Not least because usual convention would suggest the ',' is in the wrong place.

It's a sloppy rns I guess which is a shame. But the final '1' on the total new share number and two of its constituents is actually a (1), which is a reference to a note. And unhelpfully the note doesn't appear on this rns.

245ktonnes @c.500usd per tonne. Per annum.
C. 60% ebitda if memory is correct.

Quite attractive.